Dr. Sarah Butler joined Dynamill Research as Chief Operations Officer in 2025. Most recently, she served as the Vice President, Clinical & Medical Affairs for Perimeter Medical Imaging AI, and prior to that, as the Executive Director, Clinical Affairs at IBM Watson Health AI, conducting medical device clinical trials using AI in oncology. Her prior 15+ years of experience in clinical and research testing included extensive healthcare industry experience and a reputation as an expert in global medical education and scientific communication, healthcare systems, clinical trial strategy, conduct, and compliance in clinical and industry environments. Dr. Butler was Director of the Clinical Cytogenetics Diagnostic Laboratory at Cincinnati Children’s Hospital Medical Center and Assistant Professor of Pediatrics at the University of Cincinnati College of Medicine. She holds a Bachelor of Science in Biology–Genetics from Heidelberg College and a PhD in Biomedical Biology–Molecular Genetics and Molecular Physiology from the University of Dayton. Dr. Butler was a Clinical Postdoctoral Cytogenetics Fellow at Cincinnati Children’s Hospital Medical Center.